# Li-Fraumeni Syndrome/TP53 Biobank

> **NCT04367246** · — · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 300 (estimated)

## Conditions studied

- Li-Fraumeni Syndrome
- Li-Fraumeni-Like Syndrome

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT04367246
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-24
- **Primary completion:** 2029-09-24
- **Final completion:** 2029-09-24
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367246, "Li-Fraumeni Syndrome/TP53 Biobank". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04367246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*